Showing results (21-30 of 580) with videos related to

Sort By:
Pageof 58
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2024
Elevated Baseline Mean Corpuscular Volume Predicts the Development of Severe Hematologic Toxicity After 177Lu-DOTATATE TherapyAndrew F Voter, Andrei Gafita, Rudolf A Werner, et al.
Clinical Nuclear Medicine|March 17, 2023
Partial Response Upon Peptide Receptor Radionuclide Therapy in a Highly Proliferative Pancreatic Neuroendocrine TumorAlexander Weich, Sebastian E Serfling, Steven P Rowe, et al.
Seminars in Nuclear Medicine|October 16, 2025
Recent Advances and Future Trends of[18F]-Labeled PET Agents for Renal ImagingTakahiro Higuchi, Xinyu Chen, Sophie C Siegmund, et al.
Seminars in Nuclear Medicine|May 26, 2023
Role of Functional SPECT and PET in Renal EmergenciesTakahiro Higuchi, Philipp E Hartrampf, Andreas K Buck, et al.
PET Clinics|October 13, 2022
18F-Labeled Radiotracers for Prostate-specific Membrane Antigen: Historical Perspective and Future DirectionsSteven P Rowe, Ali Salavati, Rudolf A Werner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 31, 2019
The next era of renal radionuclide imaging: novel PET radiotracersRudolf A Werner, Xinyu Chen, Constantin Lapa, et al.
Seminars in Nuclear Medicine|June 23, 2019
Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important PitfallsSara Sheikhbahaei, Rudolf A Werner, Lilja B Solnes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 26, 2016
Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging AgentHiroshi Wakabayashi, Rudolf A Werner, Nobuyuki Hayakawa, et al.
Pageof 58